Skip to Content

Vusion Approval History

  • FDA approved: Yes (First approved February 16th, 2006)
  • Brand name: Vusion
  • Generic name: miconazole nitrate, zinc oxide and white petrolatum
  • Dosage form: Ointment
  • Previous name: Zimycan
  • Company: Barrier Therapeutics, Inc.
  • Treatment for: Cutaneous Candidiasis

Vusion (miconazole nitrate, zinc oxide and white petrolatum) is a steroid-free ointment for the treatment of diaper dermatitis.

Development History and FDA Approval Process for Vusion

Feb 16, 2006Approval Vusion Approved - Barrier Therapeutics, Inc. - Treatment for Diaper Dermatitis Complicated by Candidiasis
Oct 12, 2005Barrier Therapeutics Submission for Zimycan Deemed a Complete Response by FDA
May 25, 2005Barrier Therapeutics Receives Not Approvable Letter From the FDA for Zimycan
Nov 29, 2004Barrier Therapeutics Submits Amendment to NDA for U.S. Regulatory Approval of Zimycan

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.